FDA Inspection 1215469 — Louisville Reproductive Center
The FDA completed an inspection of Louisville Reproductive Center on Aug 22, 2023 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 22, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Louisville, KY (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12242 | 21 CFR 1271.55(c) | Name and personal info on accompanying records |